Twitter Beğeni Hilesi

Membranous nephropathy: new pathogenic mechanisms and their clinical implications ca. 2022 from Nature Reviews Nephrology #GlomConHawaii 🇺🇸 #Nephpearls 👉🏼 pubmed.ncbi.nlm.nih.gov/35484394/

▶️¿Quieres visualizar las últimas Jornadas de Grupos de Trabajo S.E.N.? 👉👉Accede al canal de @Youtube de la Sociedad en youtube.com/@SENefrologia

The #nephrologyguru & #mentor #thanksforsharing your knowledge. #DEP #Nephrologist will remember you forever. #Nephronnumber #transformingNephrology

A sad day for Nephrology . He inspired so many of us .. A true giant of Academic Medicine and a great intellect. He made Nephrology great throught his many outstanding fellows who became nephrology leaders nationally and workd wide. Rest in peace

Mi reflexión sobre el FINEARTS-HF con lo q sabemos ya, en pacientes con IC leve⬇️ o ICFEp, finerenona: 1. Objetivo 1✅: ☠️+ IC💔 2. FG> 60 > 50% pacientes 3. UACR<30= > 60% pac. 4.DM2= 40% pac. 5. IMC>30= 45% pac. Hilo ➡️(2) onlinelibrary.wiley.com/doi/10.1002/ej…

IgA Nephropathy (IgAN): Treatment Pillars ca. 2024 from MDPI Jonathan Barratt Dana Rizk #Nephpearls 📌 Optimal supportive care 1⃣ Mitigating consequences of ongoing nephron loss 2⃣ Halting glomerular inflammation 3⃣ Reducing production of Gd-IgA1 4⃣ Stopping

🧐¿Presentas una Comunicación Oral, e-Poster o Poster en el 54 Congreso de la S.E.N. #Senefro24? ¡Esta información te interesa! 📂Ya disponible la subida de archivos | Accede a las instrucciones, forma de acceso a la plataforma, plazos y plantillas: congresosen.com/2024/subida-ar…

➡️Genetics of Chronic Kidney Disease #adpkd #alportsyndrome #adtkd #kidneydisease #GTERH New England Journal of Medicine nejm.org/doi/full/10.10…

Happy to share the results of this clinical trial in which pentoxifylline reduced atherosclerosis progression in patients with diabetes and CKD, a beneficial effect related to Klotho gene expression. cardiab.biomedcentral.com/articles/10.11… Instituto de Salud Carlos III (ISCIII) S.E.N. Nefrología Sanidad Gobcan Instituto de Tecnologías Biomédicas

I'm excited to see this true GFR measurement drug/device nearing FDA approval. Imagine injecting a inert fluoroprobe, slapping a pulse-ox like monitor on them and in less than 1 hr knowing their mGFR. You could also monitor for changes in mGFR over12-24h. kidney-international.org/article/S0085-…

GLP-1 RA reduces CV events & CKD progression, independent of SGLT2i - supporting combination therapy with both agents to improve cardio-renal outcomes in type 2 diabetes Our most comprehensive analysis yet, #simpub in Circulation for #ESCCongress ahajournals.org/doi/abs/10.116…

🔴Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in type 2 diabetes: the #FLOW trial #ESCCongress 🧑‍🤝‍🧑3533 ⏰3.4 years. 📌Semaglutide ⬇️ CV death/MI/stroke by 18% with consistency across eGFR categories, UACR levels and KDIGO risk classification

🥁🥁Semaglutida oral vs subcutánea en ERC: experiencia de nuestra serie!!! ✳️ Eficacia en control de glicada y en descenso de peso similares 👇🏼👇🏼👇🏼 mdpi.com/2077-0383/13/1…

1/n New #Hypertension guidelines- it is simply excellent (and unlike other guidelines does not guarantee to put you to sleep!) Find it here: academic.oup.com/eurheartj/adva… Short 🧵 Hypertension AND separate Elevated Blood pressure categories Screen everyone >40yrs annually

Pooled data from ~15,000 pts in 4-RCTs examining the relationship b/w NT-proBNP, kidney function & outcomes in HFpEF Data which calls into question proposals for higher NT-proBNP references ranges in people with CKD #Simpub in JACC-HF for #ESCCongress sciencedirect.com/science/articl…

🔴🔴Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction ⏰32 months 👉Finerenone ⬇️16%RR primary endpoint ⬇️12%RR total number of worsening heart failure events. 🔴No significant difference in CV💀 ⬆️ risk of hyperkalemia and a reduced risk of

Cómo ver a través de la piel: diseñan una técnica que hace los tejidos transparentes eldiario.es/sociedad/disen…

Preventing gastrointestinal side effects after GLP-1 RAs. mdpi.com/2077-0383/12/1… You can also download the images to give to your patients (free) in both English and Spanish." English drive.google.com/file/d/1qOdXGo… Spanish (Español) drive.google.com/file/d/1iWFA55… EASD

Fui a una charla en el #EASD2024 sobre Nefropatia Diabética. Preocupa la baja percepción y screening de pacientes y médicos respectivamente. Me quedo con la última diapositiva que deberíamos llevar los médicos en nuestra mente y nuestro corazón: La obligación de actuar !

Hablando de #ERC en #EASD2024: ✅ DARWIN-RENAL: estudio comparativo de #iSGLT2 y #arGLP1 en práctica clínica habitual sobre objetivos renales: ✳️ iSGLT2 se asocia con una mejor preservación de la función renal sin diferencias en la reducción de albuminuria